Product NDC: | 17478-540 |
Proprietary Name: | Hydromorphone Hydrochloride |
Non Proprietary Name: | Hydromorphone Hydrochloride |
Active Ingredient(s): | 10 mg/mL & nbsp; Hydromorphone Hydrochloride |
Administration Route(s): | PARENTERAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-540 |
Labeler Name: | Akorn |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078228 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100515 |
Package NDC: | 17478-540-05 |
Package Description: | 10 AMPULE in 1 CARTON (17478-540-05) > 5 mL in 1 AMPULE |
NDC Code | 17478-540-05 |
Proprietary Name | Hydromorphone Hydrochloride |
Package Description | 10 AMPULE in 1 CARTON (17478-540-05) > 5 mL in 1 AMPULE |
Product NDC | 17478-540 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydromorphone Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | PARENTERAL |
Start Marketing Date | 20100515 |
Marketing Category Name | ANDA |
Labeler Name | Akorn |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |